DEDIFFERENTIATION OF NON-HEMATOPOIETIC TISSUE BY GENETIC MANIPULATION AND ITS ACQUISITION OF PLASTICITY AND HEMATOPOIETIC TRANSDIFFERENTIATION

通过基因操作实现非造血组织的去分化及其可塑性和造血转分化的获得

基本信息

  • 批准号:
    16390281
  • 负责人:
  • 金额:
    $ 7.68万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2004
  • 资助国家:
    日本
  • 起止时间:
    2004 至 2005
  • 项目状态:
    已结题

项目摘要

We explored the possibility that genetic manipulation may enhance the efficiency of transdifferentiation of non-hematopoietic tissue. Transient overexpression of Msx1 in muscles was reported to generate abundant mononuclear cells (MNCs) capable of differentiation into myotubes, chondrocytes, adipocytes and osteocytes. Since virtually all of AAV vector-mediated transgenes exist as a non-integrated form, they gradually disappear as the host cells divide. We took advantage of this feature of AAV vectors ; i.e. muscle-derived MNCs lose Msx1 transgenes through multiple cell divisions after dedifferentiation. We postulated that a proper differentiation cue might redirect muscle-derived undifferentiated MNCs into a hematopoietic lineage. AAV5 vector expressing Msx1 (AAV-msx1) was injected into tibialis anterior muscles of C57BL/6 mice. Flow cytometric analysis revealed that MNCs from AAV-msx1-treated muscles contained a considerable number of cells expressing hematopoietic stem cell markers. To evaluate hematopoietic activity, MNCs were cultured in methylcellulose medium. After AAV-msx1 injection, colony-forming cells in the muscles were gradually increased, reaching a peak at 3 wk. In vivo hematopoietic reconstitution activity was also evaluated by transplanting MNCs from AAV-msx1-treated muscles of Ly5.2 mice to irradiated congenic mice. Efficient engraftment of Ly5.2 cells was observed, and these transplants showed a very high chimerism of Ly 5.2. Furthermore, in the secondary bone marrow transplantation from the former mouse to a Ly5.1/5.2 heterozygous recipient, the donor cell chimerism was even higher. These results suggest that enforced Msx1 expression can reprogram muscle cells into multipotential cells capable of differentiation into a hematopoietic lineage as well. This novel technology would be applied to the treatment of acquired bone marrow failure using genetically-normal hematopoietic stem cells derived from patient muscles.
我们探索了基因操作可能提高非造血组织转分化效率的可能性。据报道,肌肉中 Msx1 的瞬时过度表达会产生丰富的单核细胞 (MNC),能够分化为肌管、软骨细胞、脂肪细胞和骨细胞。由于几乎所有 AAV 载体介导的转基因都以非整合形式存在,因此它们会随着宿主细胞分裂而逐渐消失。我们利用了AAV载体的这一特性;即肌肉来源的 MNC 在去分化后通过多次细胞分裂失去 Msx1 转基因。我们假设,适当的分化线索可能会将肌肉来源的未分化 MNC 重定向到造血谱系。将表达 Msx1 (AAV-msx1) 的 AAV5 载体注射到 C57BL/6 小鼠的胫骨前肌中。流式细胞分析显示,来自 AAV-msx1 处理肌肉的 MNC 含有大量表达造血干细胞标记物的细胞。为了评估造血活性,在甲基纤维素培养基中培养 MNC。注射AAV-msx1后,肌肉中的集落形成细胞逐渐增多,在3周时达到峰值。还通过将经 AAV-msx1 处理的 Ly5.2 小鼠肌肉中的 MNC 移植到受辐射的同系小鼠中来评估体内造血重建活性。观察到 Ly5.2 细胞的有效植入,并且这些移植物显示出非常高的 Ly 5.2 嵌合性。此外,在从前小鼠到Ly5.1/5.2杂合受体的二次骨髓移植中,供体细胞嵌合性甚至更高。这些结果表明,强制表达 Msx1 可以将肌肉细胞重新编程为能够分化为造血谱系的多能细胞。这项新技术将利用来自患者肌肉的基因正常的造血干细胞来治疗获得性骨髓衰竭。

项目成果

期刊论文数量(83)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Fragl, a homolog of altemative replication factor C subunits, links replication stress surveillance with apoptosis.
Fragl 是替代复制因子 C 亚基的同源物,将复制应激监视与细胞凋亡联系起来。
Removal of empty capsids from type 1 adeno-associated virus vector stocks by anion-exchange chromatography potentiates transpene expression.
通过阴离子交换层析从 1 型腺相关病毒载体原液中去除空衣壳可增强 transpene 表达。
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Urabe;M.
  • 通讯作者:
    M.
Large-scale production of recombinant viruses by use of a large culture vessel with active gassing.
使用具有主动通气功能的大型培养容器大规模生产重组病毒。
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Okada;T.;Nomoto;T.;Yoshioka;T.;Nonaka-Sarukawa;M.;Ito;T.;Ogura;T.;Iwata-Okada;M.;Uchibori;R.;Shimazaki;K.;Mizukami;H.;Kume;A.;Ozawa;K.
  • 通讯作者:
    K.
Hematopoietic microchimerism in sheep after in utero transplantation of cultured cynomolgus embryonic stem cells.
培养的食蟹猴胚胎干细胞宫内移植后绵羊的造血微嵌合。
Separate control of Rep and Cap expression utilizing mutant and wild-type loxP sequences and improved packaging system for adeno-associated virus vector production.
利用突变型和野生型 loxP 序列以及改进的腺相关病毒载体生产包装系统单独控制 Rep 和 Cap 表达。
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Mizukami H;et al.
  • 通讯作者:
    et al.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

OZAWA Keiya其他文献

OZAWA Keiya的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('OZAWA Keiya', 18)}}的其他基金

Development of a site-specific gene insertion technology for regenerative medicine:Basic study using developmental engineering
再生医学定点基因插入技术的开发:利用发育工程的基础研究
  • 批准号:
    23659493
  • 财政年份:
    2011
  • 资助金额:
    $ 7.68万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Development of gene therapy using bone-marrow-derived mesenchymal stem cells
使用骨髓间充质干细胞进行基因治疗的开发
  • 批准号:
    21390296
  • 财政年份:
    2009
  • 资助金额:
    $ 7.68万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of gene therapy for malignant lymphoma using mesenchymal stem cells with tumor-accumulating capacity
利用具有肿瘤蓄积能力的间充质干细胞开发恶性淋巴瘤基因治疗
  • 批准号:
    19390267
  • 财政年份:
    2007
  • 资助金额:
    $ 7.68万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of AAV (adeno-associated virus) vectors and their application to cancer therapy
AAV(腺相关病毒)载体的开发及其在癌症治疗中的应用
  • 批准号:
    17016067
  • 财政年份:
    2005
  • 资助金额:
    $ 7.68万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
Development of the gene therapy technologies using adeno-associated virus (AAV)
使用腺相关病毒(AAV)的基因治疗技术的开发
  • 批准号:
    12470203
  • 财政年份:
    2000
  • 资助金额:
    $ 7.68万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development and application of the technologies for manipulationg hematopoietic stem cells using cell-regulatory genes
细胞调控基因操控造血干细胞技术的开发与应用
  • 批准号:
    11557075
  • 财政年份:
    1999
  • 资助金额:
    $ 7.68万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Development of the method for chromosomal site-specific integration of transgenes using AAV and its application to hematopoietic cells
AAV转基因染色体位点特异性整合方法的开发及其在造血细胞中的应用
  • 批准号:
    10470213
  • 财政年份:
    1998
  • 资助金额:
    $ 7.68万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of a novel regulatory gene for in vivo & in vitro expansion of transduced hematopoietic stem cellss
开发一种新型体内调节基因
  • 批准号:
    09557087
  • 财政年份:
    1997
  • 资助金额:
    $ 7.68万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of a novel gene therapy technology for site-specific integration of large-sized genes
开发用于大尺寸基因位点特异性整合的新型基因治疗技术
  • 批准号:
    08457280
  • 财政年份:
    1996
  • 资助金额:
    $ 7.68万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular study of hematopoiesis-supporting ability of C3H10T1/2 mouse embryo fibroblasts
C3H10T1/2小鼠胚胎成纤维细胞造血支持能力的分子研究
  • 批准号:
    06454345
  • 财政年份:
    1994
  • 资助金额:
    $ 7.68万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似国自然基金

基因编辑诱导星型胶质细胞转分化为运动神经元治疗肌萎缩脊髓侧索硬化的机制研究
  • 批准号:
    82371443
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
TET2调控肺腺鳞癌转分化的功能和机制研究
  • 批准号:
    82372763
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
MAP3K1基因变异通过GEFT诱导睾丸向卵巢转分化的分子机制研究
  • 批准号:
    82300888
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
PTBP-1调控星形胶质细胞转分化介导UCMSC-Exos改善MIA-HIE机制的研究
  • 批准号:
    82301549
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Alcohol Regulation of Endothelial Plasticity in Atherosclerosis
酒精对动脉粥样硬化内皮可塑性的调节
  • 批准号:
    10585070
  • 财政年份:
    2023
  • 资助金额:
    $ 7.68万
  • 项目类别:
Elucidating the Role of Microenvironment Mechanics in Regulating Cardiac Myofibroblast Plasticity
阐明微环境力学在调节心脏肌成纤维细胞可塑性中的作用
  • 批准号:
    10570135
  • 财政年份:
    2023
  • 资助金额:
    $ 7.68万
  • 项目类别:
Endothelial Regulation of Astrocyte Trans-differentiation in Stroke
中风中星形胶质细胞转分化的内皮调节
  • 批准号:
    10712315
  • 财政年份:
    2023
  • 资助金额:
    $ 7.68万
  • 项目类别:
The CCK-B receptor signaling pathway as a driver of pancreatic cellular plasticity and carcinogenesis
CCK-B 受体信号通路作为胰腺细胞可塑性和癌变的驱动因素
  • 批准号:
    10578371
  • 财政年份:
    2023
  • 资助金额:
    $ 7.68万
  • 项目类别:
Determining the role and function of a high plasticity cell state in lung adenocarcinoma
确定高可塑性细胞状态在肺腺癌中的作用和功能
  • 批准号:
    10525396
  • 财政年份:
    2022
  • 资助金额:
    $ 7.68万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了